Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Jaffe

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
European Heart Journal|December 17, 2008
Higher sensitivity troponin assays: Quo vadis?H A Katus, E Giannitsis, A S Jaffe, et al.
The American Journal of Cardiology|May 15, 1990
Prognostic significance of mitral regurgitation in acute myocardial infarction. The MILIS Study GroupB Barzilai, V G Davis, P H Stone, et al.
Clinical Chemistry|February 1, 1988
Quantitative analysis for isoforms of creatine kinase MM in plasma by chromatofocusing, with on-line monitoring of enzyme activityR Nohara, B E Sobel, A S Jaffe, et al.
American Heart Journal|May 1, 1988
Relationship of QRS scoring system to enzymatic and pathologic infarct size: the role of infarct locationH J Eisen, B Barzilai, A S Jaffe, et al.
Thrombosis Research|April 1, 1987
Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarctionP R Eisenberg, L A Sherman, J Perez, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1984
Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failureA S Jaffe, C Ritter, V Meltzer, et al.
Circulation|July 1, 1981
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagenA S Jaffe, E M Geltman, G E Rodey, et al.
Neurology|February 13, 2003
Evidence of cardiac ischemia during seizures in drug refractory epilepsy patientsS Tigaran, H Mølgaard, R McClelland, et al.
Herz|April 1, 1981
Nifedipine and acute myocardial infarctionR Roberts, A S Jaffe, P D Henry, et al.
American Heart Journal|October 1, 1990
Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activatorM L Cohen, B Barzilai, F Gutierrez, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
European Heart Journal|December 17, 2008
Higher sensitivity troponin assays: Quo vadis?H A Katus, E Giannitsis, A S Jaffe, et al.
The American Journal of Cardiology|May 15, 1990
Prognostic significance of mitral regurgitation in acute myocardial infarction. The MILIS Study GroupB Barzilai, V G Davis, P H Stone, et al.
Clinical Chemistry|February 1, 1988
Quantitative analysis for isoforms of creatine kinase MM in plasma by chromatofocusing, with on-line monitoring of enzyme activityR Nohara, B E Sobel, A S Jaffe, et al.
American Heart Journal|May 1, 1988
Relationship of QRS scoring system to enzymatic and pathologic infarct size: the role of infarct locationH J Eisen, B Barzilai, A S Jaffe, et al.
Thrombosis Research|April 1, 1987
Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarctionP R Eisenberg, L A Sherman, J Perez, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1984
Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failureA S Jaffe, C Ritter, V Meltzer, et al.
Circulation|July 1, 1981
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagenA S Jaffe, E M Geltman, G E Rodey, et al.
Neurology|February 13, 2003
Evidence of cardiac ischemia during seizures in drug refractory epilepsy patientsS Tigaran, H Mølgaard, R McClelland, et al.
Herz|April 1, 1981
Nifedipine and acute myocardial infarctionR Roberts, A S Jaffe, P D Henry, et al.
American Heart Journal|October 1, 1990
Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activatorM L Cohen, B Barzilai, F Gutierrez, et al.
Pageof 17